Chordia Therapeutics,Inc【JP:190A】Cash flow
Market cap
¥8.5B
P/E ratio
-4.3x
| 2022/08 | 2023/08 | 2024/08 | 2025/08 | |
| Depreciation & amortization | 3 | 6 | 4 | 3 |
| Cash from operations | -1,704 | 544 | -1,937 | -1,837 |
| Capital expenditures | -9 | -0 | -1 | -5 |
| Cash from investing | -15 | 0 | -11 | -5 |
| Cash from financing | 3,976 | - | 1,479 | 62 |
| Free cash flow | ||||
| FCF margin (%) | - | - | - |